In this study, investigators will examine the behavioral effects and neurophysiological mechanisms of the pro-social neuropeptide oxytocin in patients with recent-onset schizophrenia. Such research is a necessary first step towards identifying whether intranasal oxytocin administration can serve as an adjunct treatment for social impairments in schizophrenia. Aim 1: To examine the effects of exogenous oxytocin on patterns of neural activation as measured by fMRI during a well-characterized affect-labeling task in patients with recent-onset schizophrenia and healthy comparison subjects. Hypothesis A: Patients will exhibit amygdalar hyperactivity and PNS hypo-activity when passively viewing faces, which will be normalized by administration of oxytocin. Hypothesis B: Patients will exhibit hypo-activity of the vPFC when affectively labeling faces and this hypo-activity will be normalized by oxytocin administration.
Mechanisms and Effects of Oxytocin on Social Cognition in Schizophrenia - fMRI
SchizophreniaOxytocinSocial CognitionFunctional Magnetic Resonance Imaging (fMRI)Syntocinon
You can join if…
Open to males ages 18–50
SCID-IV confirmed diagnosis of schizophrenia or schizoaffective disorder
No changes to medications for the past week
Inclusion Criteria for Healthy Controls:
SCID-IV confirmed no diagnosis of a current Axis I disorder within the last year
You CAN'T join if...
for Patients and Healthy Controls:
Meeting criteria for current substance abuse or dependence or illicit drug use within the last month (nicotine use is acceptable) as determined by a Urine Toxicology Drug Screening
Any illness that affects the nasal passages and impairs the delivery of a nasal spray
Presence of any neurological or significant medical disorder, including medical illnesses that could interfere with physiological recording such as cardiac arrhythmias
A pacemaker, extensive dental work, or any magnetic metal implants and upper body tattoos
A history of seizures
Failure to receive a passing score on the reading test
Additional Exclusion Criteria for Patients and Healthy Controls:
Taking any psychotropic medication or any medication that affects the autonomic or cardiovascular systems.
Schizophrenia or other psychotic disorder in a first degree relative
Failure to receive a passing score on the MOCA
San Francisco Veterans Affairs Medical Centeraccepting new patients San Francisco, California, 94121, United States
University of California, San Franciscoaccepting new patients San Francisco, California, 94143, United States